Teza Capital Management LLC Has $392,000 Stock Position in HCA Healthcare, Inc. $HCA

Teza Capital Management LLC lowered its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 81.3% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 1,135 shares of the company’s stock after selling 4,931 shares during the period. Teza Capital Management LLC’s holdings in HCA Healthcare were worth $392,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the business. Price T Rowe Associates Inc. MD lifted its holdings in shares of HCA Healthcare by 83.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock worth $829,104,000 after purchasing an additional 1,091,416 shares during the period. Nuveen Asset Management LLC lifted its holdings in shares of HCA Healthcare by 4.5% during the fourth quarter. Nuveen Asset Management LLC now owns 1,865,771 shares of the company’s stock worth $560,011,000 after purchasing an additional 81,105 shares during the period. Goldman Sachs Group Inc. lifted its holdings in shares of HCA Healthcare by 49.1% during the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock worth $615,583,000 after purchasing an additional 587,036 shares during the period. GAMMA Investing LLC raised its stake in HCA Healthcare by 40,527.3% during the first quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company’s stock worth $5,887,850,000 after buying an additional 1,699,713 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in HCA Healthcare by 12.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,675,460 shares of the company’s stock worth $502,889,000 after buying an additional 188,093 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

HCA has been the subject of a number of analyst reports. Stephens raised shares of HCA Healthcare to a “strong-buy” rating in a research note on Monday, June 2nd. Wall Street Zen raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, July 5th. JPMorgan Chase & Co. lifted their price target on shares of HCA Healthcare from $360.00 to $370.00 and gave the company a “neutral” rating in a research note on Monday, August 4th. Barclays dropped their price objective on shares of HCA Healthcare from $416.00 to $390.00 and set an “overweight” rating on the stock in a report on Monday, July 28th. Finally, Wells Fargo & Company dropped their price objective on shares of HCA Healthcare from $385.00 to $375.00 and set an “equal weight” rating on the stock in a report on Thursday, August 14th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $401.83.

HCA Healthcare Trading Up 2.2%

NYSE:HCA opened at $420.68 on Monday. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. The firm has a 50-day moving average of $380.14 and a 200-day moving average of $360.39. The company has a market cap of $98.43 billion, a PE ratio of 17.68, a PEG ratio of 1.32 and a beta of 1.41. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $420.98.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same period in the previous year, the firm posted $5.50 earnings per share. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be issued a dividend of $0.72 per share. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare’s payout ratio is 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.